USUnited StatesHealthtentative
PDUFA date: ifinatamab deruxtecan (Merck/Daiichi Sankyo) in small cell lung cancer
A highly anticipated new antibody-drug conjugate for Merck.
- News
- 2/5
- Markets
- 4/5
- Overall
- 3/5
Shared from the PPN World agenda
A highly anticipated new antibody-drug conjugate for Merck.
Know what's coming. Read it the second it lands.
PPN World puts the world's scheduled set pieces — central banks, data, elections, summits — beside every press release from 1,400+ feeds in 190+ countries, live. Filter by country, export to your calendar, get alerted.
Cancel anytime · CA$99/month
Open the agenda in PPN World →About the World Agenda →
Shared via PPN World — real-time press release intelligence.